Non-Hodgkin Lymphoma

Filter By:
Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma and it can be aggressive. Drs. John Gribben and Wyndham Wilson discuss new research shows promise for many. Get email alerts | http://www.p... Subscribe on YouTube | http://www.y... Like on Facebook | http://ww......
by:patientpower | 72 views
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA), Prof Anton Hagenbeek (Academic Medical Center, Amsterdam, Netherlands), Prof Michael Pfreundschuh (University of Saarland, Homburg-Saar, Germany) and Dr Myron...
by:EMJ | 105 views
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Prof Randy Gascoyne (British Columbia Cancer Agency, Vancouver, Canada), Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA) and Dr Myron Czuczman (Roswell Park Cancer Institute, Buffalo, USA) about the highligh...
by:EMJ | 118 views
Recorded at the 2014 International Workshop on Non-Hodgkin Lymphoma, Dr. Owen O’Connor gives an update on brentuximab vedotin (Adcetris), an antibody drug conjugate (ADC) approved for the treatment of CD30-positive lymphomas, like anaplastic large-cell lymphoma and Hodgkin lymphoma. Dr. O’Connor exp...
by:patientpower | 325 views
Watch as Dr. Owen O’Connor gives us an overview of the state of treatment for T-Cell lymphoma and the latest news on emerging therapies. Despite a historical challenge in treating T-cell lymphomas, Dr. O’Connor is encouraged by the recent drug approvals and ongoing clinical trials into the use of histone deacetylase (HDAC) inhibitors both as single...
by:patientpower | 351 views
Novel agents emerging for the treatment of lymphoma are offering some patients the opportunity of long-term disease control while avoiding aggressive and highly toxic chemotherapy therapies. For the time being, this means changing the goal of treatment from cure to control. Can patients live well wi...
by:patientpower | 740 views
Where are we now with treatment approaches for follicular and indolent lymphomas? What is in store for the near future? How are monoclonal antibodies changing therapy today? In this video, Dr. Wyndham Wilson, from the National Cancer Institute, joins Dr. John Gribben, from the Barts Cancer Center in London, at the 2014 International Workshop on Non...
by:patientpower | 247 views
How can you tell if you might have Follicular Lymphoma (FL), a common type of indolent non-Hodgkin lymphoma (NHL). Learn the signs and symptoms from Dr. Wyndham Wilson from the National Cancer Institute (NCI). Read the transcript | http://www.p...-...
by:patientpower | 1064 views
Newly approved medications are beginning to offer patients with indolent lymphomas new options for continuous disease control, while avoiding some of the side effects of traditional chemotherapy treatments. The question for many patients is whether or not these drugs might extend their lives longer ...
by:patientpower | 441 views
Patients with cancer undergoing chemotherapy and radiation may be at risk for Oral Mucositis, a condition characterized by redness, inflammation and ulcer like sores throughout the mouth and throat. Oral Mucositis can be extremely painful and may also lead to infection. The following tips can be hel...
by:DARABioSciences | 1566 views
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)